Dr. Alan Scott Polackwich Jr., MD

Dr. Polackwich practices at Mount Sinai Medical Center in Miami Beach, Florida, part of Mount Sinai Medical Center of Florida.

Dr. Polackwich's NPI, 1518128768, was assigned on June 20, 2008. Dr. Polackwich graduated from University Of Florida College Of Medicine in 2008. Dr. Polackwich holds Florida license 124501.

Dr. Polackwich's primary practice is Mount Sinai Medical Center, at 4300 Alton Rd, Miami Beach, FL 33140 in Miami-Dade County. The practice phone is (305) 674-2121.

Dr. Polackwich's primary practice is Mount Sinai Medical Center in Miami Beach, Florida, part of Mount Sinai Medical Center of Florida. The medical group on file is Mount Sinai Medical Center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Polackwich practices. Vendor and product names are available with a free account.

Urology is Dr. Polackwich's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Polackwich is board certified in urology by the American Board of Urology. Dmand AI has Dr. Polackwich's licenses on file in 3 states: Florida, Oregon and Ohio.

Dmand AI lists bladder disease, enlarged prostate, erectile dysfunction, kidney cysts, kidney removal surgery, kidney stone disease, prostate inflammation or infection and testicular dysfunction among the conditions Dr. Polackwich treats.

CMS data shows 1,249 Medicare services from Dr. Polackwich across 12 procedure codes in 2024, for 675 Medicare patients. Medicare paid $107,067 for them.

CMS counts 675 Medicare patients who saw Dr. Polackwich in 2024. The largest group is 65 to 74, with 283 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 14% are also on Medicaid. Their average risk score is 1.54, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Polackwich's median patient age at 65, with 15% women.

In 2024, Dr. Polackwich wrote 1,540 Medicare Part D claims for 513 patients. 88% of them were for generic drugs. CMS names the drug for 1,356 of them, across 22 drugs with 11 or more claims each, at $374,027 in total drug cost. In 2023, CMS named 1,159 claims across 24 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Polackwich for performance year 2024, reported as part of a group. Dr. Polackwich accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Polackwich as offering telehealth.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 20 papers to Dr. Polackwich, published from 2012 to 2022. 2015 was the busiest year, with 4. The most frequent topics are Prostatitis. Dr. Polackwich has published most often in J Urol. Dr. Polackwich's most frequent co-authors are Eugene Fredrick Fuchs, MD, Kevin Allen Ostrowski, MD and Michael Joseph Conlin, MD.

CMS Open Payments shows 235 general payments to Dr. Polackwich from 44 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 54% of the total. Boston Scientific Corporation paid the most, $8,043.

Dr. Polackwich graduated from University Of Florida College Of Medicine in 2008.

Dr. Polackwich is in network with 16 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.